Works matching IS 15747891 AND DT 2024 AND VI 18 AND IP 3

Results: 19

Retraction: p53 loses grip on PIK3CA expression leading to enhanced cell survival during platinum resistance.

Published in:: Molecular Oncology, 2024, v. 18, n. 3, p. 778, doi. 10.1002/1878-0261.13615
Publication type:: Article

PLK1 and FoxM1 expressions positively correlate in papillary thyroid carcinoma and their combined inhibition results in synergistic anti‐tumor effects.

Published in:

Molecular Oncology, 2024, v. 18, n. 3, p. 691, doi. 10.1002/1878-0261.13610

By:

Poyil, Pratheesh Kumar;
Siraj, Abdul K.;
Padmaja, Divya;
Parvathareddy, Sandeep Kumar;
Thangavel, Saravanan;
Alobaisi, Khadija;
Diaz, Roxanne;
Begum, Rafia;
Haqawi, Wael;
Al‐Sobhi, Saif S.;
Al‐Dayel, Fouad;
Al‐Kuraya, Khawla S.

Publication type:

Article

An arms‐race against resistance: leukemic stem cells and lineage plasticity.

Published in:

Molecular Oncology, 2024, v. 18, n. 3, p. 475, doi. 10.1002/1878-0261.13606

By:

Waclawiczek, Alexander;
Leppä, Aino‐Maija;
Renders, Simon;
Trumpp, Andreas

Publication type:

Article

Liprin‐α1 contributes to oncogenic MAPK signaling by counteracting ERK activity.

Published in:

Molecular Oncology, 2024, v. 18, n. 3, p. 662, doi. 10.1002/1878-0261.13593

By:

Pehkonen, Henna;
Filippou, Artemis;
Väänänen, Juho;
Lindfors, Iida;
Vänttinen, Mira;
Ianevski, Philipp;
Mäkelä, Anne;
Munne, Pauliina;
Klefström, Juha;
Toppila‐Salmi, Sanna;
Grénman, Reidar;
Hagström, Jaana;
Mäkitie, Antti A.;
Karhemo, Piia‐Riitta;
Monni, Outi

Publication type:

Article

ASPM stabilizes the NOTCH intracellular domain 1 and promotes oncogenesis by blocking FBXW7 binding in hepatocellular carcinoma cells.

Published in:

Molecular Oncology, 2024, v. 18, n. 3, p. 562, doi. 10.1002/1878-0261.13589

By:

Chan, Tze‐Sian;
Cheng, Li‐Hsin;
Hsu, Chung‐Chi;
Yang, Pei‐Ming;
Liao, Tai‐Yan;
Hsieh, Hsiao‐Yen;
Lin, Pei‐Chun;
HuangFu, Wei‐Chun;
Chuu, Chih‐Pin;
Tsai, Kelvin K.

Publication type:

Article

Single extracellular vesicle surface protein‐based blood assay identifies potential biomarkers for detection and screening of five cancers.

Published in:

Molecular Oncology, 2024, v. 18, n. 3, p. 743, doi. 10.1002/1878-0261.13586

By:

Min, Yuxin;
Deng, Wenjiang;
Yuan, Huangbo;
Zhu, Dongliang;
Zhao, Renjia;
Zhang, Pengyan;
Xue, Jiangli;
Yuan, Ziyu;
Zhang, Tiejun;
Jiang, Yanfeng;
Xu, Kelin;
Wu, Di;
Cai, Yanling;
Suo, Chen;
Chen, Xingdong

Publication type:

Article

Fatty acid synthase (FASN) signalome: A molecular guide for precision oncology.

Published in:

Molecular Oncology, 2024, v. 18, n. 3, p. 479, doi. 10.1002/1878-0261.13582

By:

Menendez, Javier A.;
Cuyàs, Elisabet;
Encinar, Jose Antonio;
Vander Steen, Travis;
Verdura, Sara;
Llop‐Hernández, Àngela;
López, Júlia;
Serrano‐Hervás, Eila;
Osuna, Sílvia;
Martin‐Castillo, Begoña;
Lupu, Ruth

Publication type:

Article

Building flexible and robust analysis frameworks for molecular subtyping of cancers.

Published in:

Molecular Oncology, 2024, v. 18, n. 3, p. 606, doi. 10.1002/1878-0261.13580

By:

Pedersen, Christina Bligaard;
Campos, Benito;
Rene, Lasse;
Wegener, Helene Scheel;
Krishnan, Neeraja M.;
Panda, Binay;
Vitting‐Seerup, Kristoffer;
Rossing, Maria;
Bagger, Frederik Otzen;
Olsen, Lars Rønn

Publication type:

Article

Dual targeting of the androgen receptor and PI3K/AKT/mTOR pathways in prostate cancer models improves antitumor efficacy and promotes cell apoptosis.

Published in:

Molecular Oncology, 2024, v. 18, n. 3, p. 726, doi. 10.1002/1878-0261.13577

By:

Sugawara, Tatsuo;
Nevedomskaya, Ekaterina;
Heller, Simon;
Böhme, Annika;
Lesche, Ralf;
von Ahsen, Oliver;
Grünewald, Sylvia;
Nguyen, Holly M.;
Corey, Eva;
Baumgart, Simon J.;
Georgi, Victoria;
Pütter, Vera;
Fernández‐Montalván, Amaury;
Vasta, James D.;
Robers, Matthew B.;
Politz, Oliver;
Mumberg, Dominik;
Haendler, Bernard

Publication type:

Article

Molecular characteristics of early‐onset pancreatic ductal adenocarcinoma.

Published in:

Molecular Oncology, 2024, v. 18, n. 3, p. 677, doi. 10.1002/1878-0261.13576

By:

Debernardi, Silvana;
Liszka, Lukasz;
Ntala, Chara;
Steiger, Katja;
Esposito, Irene;
Carlotti, Emanuela;
Baker, Ann‐Marie;
McDonald, Stuart;
Graham, Trevor;
Dmitrovic, Branko;
Feakins, Roger M.;
Crnogorac‐Jurcevic, Tatjana

Publication type:

Article

cAMP‐phosphodiesterase 4D7 (PDE4D7) forms a cAMP signalosome complex with DHX9 and is implicated in prostate cancer progression.

Published in:

Molecular Oncology, 2024, v. 18, n. 3, p. 707, doi. 10.1002/1878-0261.13572

By:

Gulliver, Chloe;
Busiau, Tara;
Byrne, Ashleigh;
Findlay, Jane E.;
Hoffmann, Ralf;
Baillie, George S.

Publication type:

Article

Development of an optimized, non‐stem cell line for intranasal delivery of therapeutic cargo to the central nervous system.

Published in:

Molecular Oncology, 2024, v. 18, n. 3, p. 528, doi. 10.1002/1878-0261.13569

By:

El‐Ayoubi, Ali;
Arakelyan, Arsen;
Klawitter, Moritz;
Merk, Luisa;
Hakobyan, Siras;
Gonzalez‐Menendez, Irene;
Quintanilla Fend, Leticia;
Holm, Per Sonne;
Mikulits, Wolfgang;
Schwab, Matthias;
Danielyan, Lusine;
Naumann, Ulrike

Publication type:

Article

Issue Information.

Published in:: Molecular Oncology, 2024, v. 18, n. 3, p. 473, doi. 10.1002/1878-0261.13457
Publication type:: Article

POTEE promotes breast cancer cell malignancy by inducing invadopodia formation through the activation of SUMOylated Rac1.

Published in:

Molecular Oncology, 2024, v. 18, n. 3, p. 620, doi. 10.1002/1878-0261.13568

By:

Martínez‐López, Angélica;
García‐Casas, Ana;
Infante, Guiomar;
González‐Fernández, Mónica;
Salvador, Nélida;
Lorente, Mar;
Mendiburu‐Eliçabe, Marina;
Gonzalez‐Moreno, Santiago;
Villarejo‐Campos, Pedro;
Velasco, Guillermo;
Malliri, Angeliki;
Castillo‐Lluva, Sonia

Publication type:

Article

PTEN‐mediated dephosphorylation of 53BP1 confers cellular resistance to DNA damage in cancer cells.

Published in:

Molecular Oncology, 2024, v. 18, n. 3, p. 580, doi. 10.1002/1878-0261.13563

By:

He, Jianfeng;
Huang, Caihu;
Guo, Yanmin;
Deng, Rong;
Li, Lian;
Chen, Ran;
Wang, Yanli;
Huang, Jian;
Zheng, Junke;
Zhao, Xian;
Yu, Jianxiu

Publication type:

Article

FBXL16 promotes cell growth and drug resistance in lung adenocarcinomas with KRAS mutation by stabilizing IRS1 and upregulating IRS1/AKT signaling.

Published in:

Molecular Oncology, 2024, v. 18, n. 3, p. 762, doi. 10.1002/1878-0261.13554

By:

Morel, Marion;
Long, Weiwen

Publication type:

Article

Hepsin promotes breast tumor growth signaling via the TGFβ‐EGFR axis.

Published in:

Molecular Oncology, 2024, v. 18, n. 3, p. 547, doi. 10.1002/1878-0261.13545

By:

Belitškin, Denis;
Munne, Pauliina;
Pant, Shishir M.;
Anttila, Johanna M.;
Suleymanova, Ilida;
Belitškina, Kati;
Kirchhofer, Daniel;
Janetka, James;
Käsper, Taivo;
Jalil, Sami;
Pouwels, Jeroen;
Tervonen, Topi A.;
Klefström, Juha

Publication type:

Article

Novel TCF4:TCF12 heterodimer inhibits glioblastoma growth.

Published in:

Molecular Oncology, 2024, v. 18, n. 3, p. 517, doi. 10.1002/1878-0261.13496

By:

Mikheeva, Svetlana A.;
Funk, Cory C.;
Horner, Philip J.;
Rostomily, Robert C.;
Mikheev, Andrei M.

Publication type:

Article

SOS2 modulates the threshold of EGFR signaling to regulate osimertinib efficacy and resistance in lung adenocarcinoma.

Published in:

Molecular Oncology, 2024, v. 18, n. 3, p. 641, doi. 10.1002/1878-0261.13564

By:

Theard, Patricia L.;
Linke, Amanda J.;
Sealover, Nancy E.;
Daley, Brianna R.;
Yang, Johnny;
Cox, Katherine;
Kortum, Robert L.

Publication type:

Article